Home Reimbursed medicines Octreotid

Octreotid — maximum prices and reimbursement

The CANAMED catalogue contains 17 medicines with the active substance Octreotid, from 3 manufacturers. Below you can see each entry with the brand name, the manufacturer, the maximum retail price, the reimbursement percentage and the prescription status — plus live pharmacy prices, where we track them.

17 CANAMED entries
3 Manufacturers
31.10–1424.68 Maximum price (RON)
5 With a reimbursement percentage
Search live prices → All reimbursed medicines →

In short: for the active substance Octreotid there are 17 authorised medicines in the CANAMED catalogue, with maximum retail prices between 31.10 and 1424.68 RON, from 3 manufacturers. For 5 of them the catalogue also records the reimbursement percentage. The maximum price is the legal cap — pharmacies may sell below it, so it is worth comparing the real price before you go. Latest import: 2026-11-03.

Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.

CANAMED catalogue

All medicines with Octreotid

Maximum retail price = the legal selling cap. Sorted by price, lowest first.

Brand name Manufacturer Maximum price Reimbursement Prescription
OCTREOTIDA ROMPHARM 0,1 mg/ml ROMPHARM COMPANY S.R.L. - ROMANIA 31.10 RON 100% · C1 (certain chronic diseases) · and C2
CNAS pays ~31.10 RON; you ~0.00 RON*		 PR _X0002_
SANDOSTATIN 100 micrograme/ml NOVARTIS PHARMA GMBH - GERMANIA 46.31 RON 100% · C1 (certain chronic diseases) · and C2
CNAS pays ~37.32 RON; you ~8.99 RON*		 PR
SANDOSTATIN LAR 10 mg NOVARTIS PHARMA GMBH - GERMANIA 629.09 RON 100% · C1 (certain chronic diseases) · and C2
CNAS pays ~629.09 RON; you ~0.00 RON*		 PR
OCTREOTIDA TEVA 10 mg MERCKLE GMBH - GERMANIA 630.47 RON not reimbursed PR
SANDOSTATIN LAR 30 mg NOVARTIS PHARMA GMBH - GERMANIA 759.82 RON 100% · C1 (certain chronic diseases) · and C2
CNAS pays ~759.82 RON; you ~0.00 RON*		 PR
OCTREOTIDA TEVA 20 mg MERCKLE GMBH - GERMANIA 966.28 RON not reimbursed PR
SANDOSTATIN LAR 20 mg NOVARTIS PHARMA GMBH - GERMANIA 1203.94 RON 100% · C1 (certain chronic diseases) · and C2
CNAS pays ~1203.94 RON; you ~0.00 RON*		 PR
OCTREOTIDA TEVA 30 mg MERCKLE GMBH - GERMANIA 1424.68 RON not reimbursed PR
OCTREOTIDA ROMPHARM 0,1 mg/ml ROMPHARM COMPANY S.R.L. - ROMANIA — not reimbursed PR _X0002_
OCTREOTIDA ROMPHARM 0,1 mg/ml ROMPHARM COMPANY S.R.L. - ROMANIA — not reimbursed PR _X0002_
OCTREOTIDA ROMPHARM 0,1 mg/ml ROMPHARM COMPANY S.R.L. - ROMANIA — not reimbursed PR _X0002_
OCTREOTIDA TEVA 10 mg MERCKLE GMBH - GERMANIA — not reimbursed PR
OCTREOTIDA TEVA 20 mg MERCKLE GMBH - GERMANIA — not reimbursed PR
OCTREOTIDA TEVA 30 mg MERCKLE GMBH - GERMANIA — not reimbursed PR
SANDOSTATIN LAR 10 mg NOVARTIS PHARMA GMBH - GERMANIA — not reimbursed PR
SANDOSTATIN LAR 20 mg NOVARTIS PHARMA GMBH - GERMANIA — not reimbursed PR
SANDOSTATIN LAR 30 mg NOVARTIS PHARMA GMBH - GERMANIA — not reimbursed PR

Reimbursement and amounts come from the CNAS nomenclature (SIUI) valid in the current month, for each pack. *What you pay is indicative: the maximum price minus what CNAS pays on the main sublist, for an insured adult. The pharmacy may sell below the maximum price; low-income pensioners, children, pupils and pregnant women may pay less. C1 applies only to the diseases on the list, and C2 within the national programmes.

Prescription status key:

  • PR _X0002_ — With a medical prescription (PR _X0002_)
  • PR — With a medical prescription (PR)

Live pharmacy prices

Products with Octreotid in our comparator

Shelf prices collected from the large chains — see on each product page where it is cheapest.

Good to know

How to read the maximum price

The CANAMED maximum retail price is the legal cap approved by the Ministry of Health — the pharmacy may sell for less, never for more. If the medicine is reimbursed, the sublist percentage (A 90%, B 50%, C1/C2 100%, D 20%) applies to the reference price of the therapeutic group, usually calculated from the cheapest product with the same INN — which is why your contribution can differ from one brand to another, even for the same active substance. The electronic prescription automatically shows the exact amount to pay; for non-prescription shelf prices, use the HartaFarmacii comparator.

CANAMED catalogue

Other active substances in the catalogue

See also the full list of reimbursed medicines, with an alphabetical index of all active substances.

Frequently asked questions

FAQ · Octreotid

  1. Is Octreotid reimbursed?
    Yes. For 5 of the catalogue entries with Octreotid we have the reimbursement percentage on record. The percentage depends on the CNAS sublist each product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and applies to the reference price of the therapeutic group, not to the shelf price. Ask the doctor or pharmacist for the exact placement.
  2. What is the CANAMED maximum price for Octreotid?
    The maximum retail prices (the CANAMED legal cap) for medicines with Octreotid are between 31.10 and 1424.68 RON. No pharmacy may sell above the maximum price, but it may sell below it — compare real prices with the HartaFarmacii comparator.
  3. What percentage of Octreotid is reimbursed?
    The percentage depends on the CNAS sublist: A 90% (common chronic diseases), B 50% (partial reimbursement), C1 and C2 100% (serious chronic diseases and national programmes), D 20%. The percentage applies to the reference price set by CNAS, not to the shelf price, so you may pay a difference even for a “100% reimbursed” medicine. You can see the exact placement on the electronic prescription.
  4. How many medicines with Octreotid are in the CANAMED catalogue?
    The CANAMED catalogue holds 17 authorised medicines with the active substance Octreotid — different brand names, strengths and pharmaceutical forms. You will find them all, with maximum price and prescription status, in the table on this page. Latest CANAMED import into the HartaFarmacii database: 2026-11-03.

Before you go

Find the best price for Octreotid

Compare prices →